Amylyx Pharmaceuticals, Inc.
AMLX • NASDAQ • Stock Fundamentals
Amylyx Pharmaceuticals, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Joshua Cohen, with a market cap of $1.5B.
Market Cap$1.5B
Employees384.0
CEOJoshua Cohen
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 7, 2026 · 1 month 7 days agoQ1 2026
View reportNext EarningsAug 6, 2026 · in 2 monthsBefore Market Open · Q2 2026
Financials
Based on Q1 2026 filing
Amylyx Pharmaceuticals, Inc. FAQ
Common questions about Amylyx Pharmaceuticals, Inc.
Amylyx Pharmaceuticals, Inc. (AMLX) has a market capitalization of $1.5B and trades on NASDAQ.
Amylyx Pharmaceuticals, Inc. has approximately 384 employees.